The present disclosure relates generally to pharmaceutical formulations. 5 Specifically, the present disclosure provides a pharmaceutical formulation comprising of solid lipid nanoparticles of Nateglinide. More specifically, the disclosure provides a pharmaceutical formulation comprising of solid lipid nanoparticles of Nateglinide and curcumin, wherein curcumin is a bio-enhancer.
Inventors
Sandeep Arora, Sonia Dhiman, Ashi Mannan
